Advertise on podcast: CHEST Pulse

This podcast episode focuses on expert perspectives on point-of-care ultrasound (POCUS) evaluation of venous congestion, including the venous excess ultrasound (VExUS) exam approach, as a practical bedside tool in different populations of patients who are critically ill. Two leading experts in this area, Abhilash Koratala, MD, and Eduardo Argaiz, MD, PhD, discuss the underlying physiology of venous congestion, key components of the exam, and real-world strategies for incorporating venous Doppler exam into clinical practice.  Presented by the Ultrasound and Chest Imaging Section of the CHEST Thoracic Oncology and Chest Procedures Network.    Moderators:  Matthew Barraza, MD, MS  Taro Minami, MD, FCCP  Madelyn Renzetti, MD, MHS-MedEd    Speakers:  Abhilash Koratala, MD  Eduardo Argaiz, MD, PhD     MORE ABOUT THORACIC ONCOLOGY AND CHEST PROCEDURES NETWORK »

This podcast offers an important discussion on the guidelines for addressing OSA in pregnancy. Hosted by Women in CHEST Medicine (WiCM) Interest Group member and guideline panelist Carolyn D’Ambrosio, MD, MS, FCCP, this episode explores why pregnancy represents a unique and often underrecognized risk period for sleep-disordered breathing and how OSA can impact both short- and long-term health outcomes for pregnant patients and their babies.   Joined by expert guest, WiCM member-at-large, and guideline panelist Ghada Bourjeily, MD, this conversation highlights new, multidisciplinary guideline recommendations designed to help clinicians better screen, diagnose, and manage OSA in pregnant patients. Listeners will gain practical insights for implementing these recommendations in real-world clinical settings, navigating challenges unique to pregnancy, and improving patient counseling and care pathways.  The goal of this episode is to raise awareness, support evidence-informed decision-making, and, ultimately, advance equitable pregnancy-related health outcomes.  Read the guideline: https://journal.chestnet.org/article/S0012-3692(26)06181-7/abstract

In Pakistan, children living with cystic fibrosis (CF) deal not only with a serious disease but also with the added complications of delayed diagnosis, limited access to therapies, and gaps in care. However, CF care is now improving in Pakistan thanks to increasing quality of life and the hard work of clinicians. In this podcast, leading CF experts from different regions of Pakistan highlight six national priorities that have the potential to transform the future of CF care, helping children with CF not only survive, but thrive. Presented by the Bronchiectasis Section of the CHEST Airways Disorders Network. Originally recorded: June 10, 2026 Moderator: Nauman A. Chaudary, MBBS, FCCP Speakers: Muhammad Fareeduddin, MBBS Nadia Salman, MBBS Iqbal Bano, MBBS

Despite triple inhaled therapy, many patients with COPD continue to experience frequent and severe exacerbations, leading to hospitalizations, symptom burden, and higher mortality risk. In this expert-led discussion, Diego J. Maselli, MD, FCCP, and Stephanie Christenson, MD, talk about personalized treatment approaches and the role of biologics in advanced COPD care.   This program is produced in partnership with the American College of Chest Physicians and is sponsored by Sanofi and Regeneron Pharmaceuticals, Inc.

In this podcast, Nicholas Villalobos, MD, interviews Hatem Soliman Aboumarie, MD, from Harefield Hospital, the Royal Brompton and Harefield Hospitals, London. They discuss cardiovascular ICU principles and updates in bedside cardiac ultrasound from the 2025 Cardiac Ultrasound in Cardiovascular Emergency and Critical Care consensus statement by the European Association of Cardiovascular Imaging, the Acute CardioVascular Care Association of the European Society of Cardiology, and the European Association of Cardiothoracic Anaesthesia and Intensive Care. This discussion involves updates in spectral Doppler, strain imaging, and applications of artificial intelligence.    Presented by the Ultrasound and Chest Imaging Section of the CHEST Thoracic Oncology and Chest Procedures Network.

In this podcast episode, in honor of Women's History Month, the Women in Chest Medicine Interest Group highlights the leadership journey, values, and insights of CHEST President-Elect Lisa K. Moores, MD, FCCP, in a conversation with host Margaret Pisani, MD, MPH, FCCP. Through a reflective and engaging discussion, Dr. Moores shares how her experiences—from competitive athletics to a distinguished military and medical career—shaped her leadership style grounded in discipline, service, inclusivity, and kindness. The episode explores the critical role of mentorship and sponsorship, addresses challenges such as work-life integration and imposter syndrome, and offers practical, actionable advice for women at all career stages in medicine.

Farrukh Abbas, MD, FCCP, and Megan Conroy, MD, MAEd, FCCP, discuss the role of the care team in COPD diagnosis, recent changes in classifications and updates to the Global Initiative for Chronic Obstructive Lung Disease guidelines, how triple-inhaler therapies and biologics can be used to treat patients with COPD, and more. Since the time of this recording, the US Food and Drug Administration has approved dupilumab as an add-on maintenance treatment for adult patients with inadequately controlled COPD with type 2 inflammation. This podcast is a part of CHEST's Bridging Specialties®: Timely Diagnosis and Treatment for COPD program. Access more resources at chestnet.org/timely-diagnosis-COPD.

Primary care providers can play a pivotal role in a patient’s COPD diagnosis by looking out for signs and symptoms and referring patients to pulmonologists when appropriate. In this podcast, Megan Conroy, MD, MEd, FCCP, and Nathan Falk, MD, MBA, CPE, CAQSM, FAAFP, provide pulmonary and primary care perspectives on diagnostic strategies for COPD. This podcast is a part of CHEST's Bridging Specialties®: Timely Diagnosis and Treatment for COPD program. Access more resources at chestnet.org/timely-diagnosis-COPD.

Early recognition and diagnosis of nontuberculosis mycobacteria (NTM) and bronchiectasis are key for optimal patient management. However, these conditions are often misdiagnosed as COPD or asthma, leading to significant challenges and delays in treatment. Join Nathan Falk, MD, MBA, and Ashwin Basavaraj, MD, FCCP, as they share perspectives on accurately diagnosing NTM and bronchiectasis with early symptom recognition, a thorough patient history, and testing. This episode is part of CHEST’s Bridging Specialties®: Timely Diagnosis for NTM Disease and Bronchiectasis program. This program is produced in partnership with CHEST and is sponsored by Insmed Incorporated.

In this episode, experts discuss the challenges of diagnosing and managing refractory chronic cough—a persistent cough that is often misunderstood and mismanaged. Drawing on findings from a recent CHEST/GSK survey, the conversation highlights gaps in patient evaluation, current treatment barriers, and opportunities to improve care through standardized protocols, better history-taking, and greater awareness of emerging therapies. This podcast is a non-promotional, non-CME educational program brought to you by CHEST in collaboration with GSK.

A man in his late 60s enters a lung cancer screening program and is found to have a 4.5 cm tumor—stage II by size, with high-stakes decisions ahead. The case seems to point toward modern perioperative therapy, until biomarker testing changes everything. In this episode, host Lisa Moores, MD, FCCP, is joined by CHEST Guideline Chair John Howington, MD, MBA, FCCP, and oncologist Natasha Leighl, MD, to show how multidisciplinary care—and molecular results—can reroute the entire treatment journey. They discuss why nodal staging matters, when perioperative therapy improves outcomes, and how biomarker-driven choices can reshape the safest path, while still leaving room for shared decision-making. Faculty  Host: Lisa Moores, MD, FCCP Guideline Chair: John Howington, MD, MBA, FCCP Case Guest: Natasha Leighl, MD

A woman in her early 60s, who never smoked in her lifetime, is diagnosed with stage II lung cancer after an abnormal chest X-ray—and believes surgery has ended the story. But postoperative pathology and molecular testing open a new chapter of therapy designed to lower recurrence risk. In this episode, host Lisa Moores, MD, FCCP, is joined by CHEST Guideline Chair John Howington, MD, MBA, FCCP, and medical oncologist Natasha Leighl, MD, to unpack how stage II decisions continue long after the operating room. They explore how staging and lymph node assessment shape what comes next; how targeted therapy can fit into survivorship; and how to counsel patients weighing work, travel, side effects, and the emotional whiplash of “I’m cured… unless I’m not.” Faculty  Host: Lisa Moores, MD, FCCP Guideline Chair: John Howington, MD, MBA, FCCP   Case Guest: Natasha Leighl, MD

A 49-year-old individual who never smoked learns a routine scan has uncovered a suspicious lung lesion—low PET uptake, a negative bronchoscopy, and “stable” imaging… yet clinical instincts say, “Don’t ignore this.” In this story-driven episode, host Lisa Moores, MD, FCCP, is joined by CHEST Guideline Chair John Howington, MD, MBA, FCCP, and thoracic surgeon Sudish Murthy, MD, PhD, FCCP, to walk through what to do when the data conflict and the stakes are real. Together, they translate the CHEST guideline “guardrails” into bedside decision-making: when surveillance stops being safe, why minimally invasive surgery matters, and how lung-sparing resection can deliver an oncologically sound plan while preserving future options. Faculty  Host: Lisa Moores, MD, FCCP Guideline Chair: John Howington, MD, MBA, FCCP Case Guest: Sudish Murthy, MD, PhD, FCCP

In the last episode of Rumblings: The CHEST 2025 Podcast, Sandhya Khurana, MD, FCCP, Chair of the Scientific Program Committee for CHEST 2025, speaks with Amy E. Morris, MD, FCCP, Chair of the Scientific Program Committee for CHEST 2026 in Phoenix about Exhibit Hall games (last chance to sign up for the escape room!), Experience CHEST, poster presentations, and what to expect at next year's annual meeting in Phoenix, October 18 to 21. The Call for Topics is open now! Submissions are due Tuesday, December 2, at 2 pm CT.

In this episode of Rumblings: The CHEST 2025 Podcast, Sandhya Khurana, MD, FCCP, Chair of the Scientific Program Committee for CHEST 2025, and Meredith Turetz, MD, FCCP, Chair of the Training and Transitions Committee, dive into the Network Open Forums at 11:15 am CT (various locations), the Trainee Lounge (South Building, Room 405), and the attendee-favorite CHEST Challenge Championship in the Arie Crown Theater (reception begins at 5 pm, event begins at 6 pm). Support your favorite CHEST Challenge team with just $5 to CHEST philanthropy by voting for your favorite mascot! Whose bovine is best?